Paper22362425
Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
Frånberg O and 2 others. Synapse, 2012. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow. Papers, record 22362425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22362425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Biogenic Monoamines | Major topic |
| Heterocyclic Compounds, 4 or More Rings | Major topic |
| Prefrontal Cortex | Major topic |
| Receptor, Serotonin, 5-HT2A | Major topic |
| Receptors, Adrenergic, alpha-2 | Major topic |
| Adrenergic alpha-2 Receptor Antagonists | |
| Amphetamines | |
| Animals | |
| Dibenzocycloheptenes | |
| Fluorobenzenes | |
| Male | |
| Microdialysis | |
| Norepinephrine | |
| Piperidines | |
| Rats | |
| Rats, Wistar | |
| Serotonin | |
| Serotonin 5-HT2 Receptor Antagonists | |
| Up-Regulation |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40623044 | Total Synthesis of Aporphine Alkaloids via Photocatalytic Oxidative Phenol Coupling and Biological Evaluation at the Serotonin 5-HT2 and Adrenergic α1A Receptors. | J Med Chem | 2025 | https://conductscience.org/library/papers/40623044 | PubMed |
| 38203411 | Molecular and Medical Aspects of Psychedelics. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203411 | PubMed |
| 36983018 | Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36983018 | PubMed |
| 36753397 | Developmental Neurotoxicity Screen of Psychedelics and Other Drugs of Abuse in Larval Zebrafish (Danio rerio). | ACS Chem Neurosci | 2023 | https://conductscience.org/library/papers/36753397 | PubMed |
| 32010308 | Attenuation of reserpine-induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol. | Exp Ther Med | 2020 | https://conductscience.org/library/papers/32010308 | PubMed |
| 28417559 | Asenapine modulates mood-related behaviors and 5-HT1A/7 receptors-mediated neurotransmission. | CNS Neurosci Ther | 2017 | https://conductscience.org/library/papers/28417559 | PubMed |
| 27356921 | Asenapine: A Review in Schizophrenia. | CNS Drugs | 2016 | https://conductscience.org/library/papers/27356921 | PubMed |
| 27236412 | Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial. | BMC Psychiatry | 2016 | https://conductscience.org/library/papers/27236412 | PubMed |
| 25522408 | Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat. | Int J Neuropsychopharmacol | 2014 | https://conductscience.org/library/papers/25522408 | PubMed |
| 25093543 | Asenapine sensitization from adolescence to adulthood and its potential molecular basis. | Behav Brain Res | 2014 | https://conductscience.org/library/papers/25093543 | PubMed |
| 24103641 | Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism. | Behav Brain Res | 2013 | https://conductscience.org/library/papers/24103641 | PubMed |
| 23954676 | Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity. | Neuropharmacology | 2013 | https://conductscience.org/library/papers/23954676 | PubMed |
| 23882123 | Nonaggressive and adapted social cognition is controlled by the interplay between noradrenergic and nicotinic receptor mechanisms in the prefrontal cortex. | FASEB J | 2013 | https://conductscience.org/library/papers/23882123 | PubMed |
| 23411676 | 5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system. | Exp Brain Res | 2013 | https://conductscience.org/library/papers/23411676 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22362425
GET https://conductscience.org/api/papers/v1/22362425/authors